Toutes nos actualités
18.05.2022
Swiss TPH Awarded Four New Research Grants in Paediatric Health
Swiss TPH has been awarded four out of six new research grants from the Principal Investigator Initiative of the Botnar Research Centre for Child Health (BRCCH). The initiative... More...
02.05.2022
Legionellosis Cases Continue to Increase in Switzerland
The number of legionellosis cases in Switzerland has increased five-fold over the past 20 years. A study by the Swiss Tropical and Public Health Institute (Swiss TPH) published... More...
01.04.2022
New Swiss TPH Headquarters Opened in Allschwil
On Friday, 1 April 2022, the new headquarters of the Swiss Tropical and Public Health Institute (Swiss TPH) officially opened in the BaseLink site, an emerging life science cluster... More...
16.03.2022
Increasing Awareness of Noma – A Severe but Treatable Disease
There is very limited data on the incidence and prevalence of noma, which hinders better management and treatment of this devastating disease that mainly affects young and... More...
25.02.2022
Gut Microbiota Influences Treatment against Parasitic Worms
Almost a quarter of the world's population is at risk of helminth infections and available treatment options are limited. Therefore, a better understanding of why anti-parasitic... More...
16.02.2022
Farewell to Dr. Mwele Ntuli Malecela, Director of the Department of Control of Neglected Tropical Diseases at WHO
It is with great sadness that we learned about the passing of Dr. Mwele Ntuli Malecela, Director of Neglected Tropical Diseases at the World Health Organization (WHO). We have lost... More...
11.02.2022
Multi-Insecticide Resistant Malaria Vectors Remain Susceptible to Malathion Insecticide
Insecticide resistant mosquitoes are a growing concern in malaria control. A study conducted by Swiss TPH and partners raises hope that multi-resistant malaria vectors remain... More...
10.02.2022
ANTICOV: Clinical Trial for COVID-19 in Low-resource Settings to Test a New Drug Combination
The need for effective COVID-19 treatments remains particularly acute, especially in sub-Saharan Africa where access to vaccines is still extremely limited. The ANTICOV clinical... More...
08.02.2022
Altitude Positively Impacts Cardiovascular Health Peruvian Study Finds
People living in high altitudes are less likely to develop metabolic syndrome, a key indicator of cardiovascular health. A study published today in PLOS One investigated the... More...
03.02.2022
Analysis of 20 Years Finds Malaria Control in Young Children Saves Lives into Adulthood
Tanzanian study of 6,700 children over two decades highlights new insights into the long-term health benefits of bed nets. More...
02.02.2022
The Swiss TPH Travel Clinic Temporarily Moves Next Door
The Swiss Tropical and Public Health Institute (Swiss TPH) recently moved into its new headquarters in the Bachgraben area in Allschwil, canton Basel-Landschaft. The Swiss TPH... More...
17.12.2021
Assessing the Potential Health Impact of Omicron
Cases of SARS-CoV-2 variant Omicron are surging in numerous settings, with early evidence suggesting Omicron is more infectious than the Delta variant. It is not yet known,... More...
13.12.2021
Health Economics to Advance Sleeping Sickness Elimination
Global health decision-makers use frameworks to support them with creating strategies to meet global elimination targets for diseases, such as sleeping sickness. In a recent study... More...
03.12.2021
Elimination on the Horizon: Prevalence of Schistosomiasis, a Neglected Tropical Disease, Decreases by Nearly 60%
In a new study by the Swiss Tropical and Public Health Institute (Swiss TPH), researchers found that the prevalence of schistosomiasis among school-aged children decreased by... More...
30.11.2021
People from Low-Income Households Severely Affected by Pandemic
The COVCO-Basel study by the Swiss Tropical and Public Health Institute (Swiss TPH) has been investigating the health-related and societal effects of the COVID-19 pandemic for over... More...
30.11.2021
Promising Drug Combination Treatment Against Parasitic Worm Infections
In a Phase III clinical trial, researchers at Swiss TPH have successfully gathered encouraging data to demonstrate higher efficacy of co-administration of ivermectin-albendazole in... More...
16.11.2021
Clinical Trials Completed for a New Drug to Treat Parasitic Worm Infections in Infants
The Pediatric Praziquantel Consortium completed its pivotal clinical Phase III trial of arpraziquantel – a potential new treatment option for the estimated 50 million... More...
09.11.2021
A Decline in Air Pollution Levels in Europe Still Fall Short of WHO Guidelines, According to New Study
A new study by Swiss TPH used robust spatio-temporal methodology to show the reduction in air pollution across Europe from 2006-2019 and found that while exposure rates have... More...